Recently, the market as a whole is in a volatile situation, investors' trading sentiment is low, and the target price reported by institutions has also become much more cautious. Data show that in the past month, securities companies have rated target prices for more than 600 listed companies, and their rating enthusiasm has weakened year-on-year. Among them, 14 stocks have more than 100% room to rise from the highest target price, mainly in the fields of medicine, biology, computer and so on.
Among the above companies, the top five companies with the largest expected increase of securities companies are: Shenzhen Fluence Technology Plc(300647) (148%), Dbappsecurity Co.Ltd(688023) (136%), Qi An Xin Technology Group Inc(688561) - U (132%), Cosco Shipping Holdings Co.Ltd(601919) (130%), Wuxi Apptec Co.Ltd(603259) (126%). On February 7, The Pacific Securities Co.Ltd(601099) securities issued a research report, giving a target price of Shenzhen Fluence Technology Plc(300647) 22.72 yuan. As of today, the closing price of the company is 9.16 yuan, 148% upward space from the target price.
Previously, Shenzhen Fluence Technology Plc(300647) announced that it planned to build a production base for key materials of lithium battery cathode, The Pacific Securities Co.Ltd(601099) securities believed that the company based on traditional heat dissipation devices, gradually contracted the low value-added business of LED traditional lighting, deeply cultivated 5g base stations, intelligent terminals, power vehicles, energy storage and other emerging heat dissipation applications, and shifted its business focus to key materials of lithium battery cathode rhythmically, The corresponding development path of the strategic field has been gradually realized. It is estimated that the company's profits from 2021 to 2023 will be -148 million yuan, 67 million yuan and 159 million yuan respectively, which is rated as buy by the company.
In addition, cro leader Wuxi Apptec Co.Ltd(603259) is favored by securities companies and has the most "buy" rating. Although the company's share price performance has been dismal due to the external influence recently, it does not reduce the institutions' bullish on leading stocks. The highest target price of the company is 210 yuan, which comes from Puyin international securities. Puyin International said: 1) the company's revenue accelerated in the fourth quarter of 21 and its core business was promoted at full speed; 2) The release of production capacity will help the performance growth continue to accelerate in 2022. It is expected that the capacity of small molecule CRDM will increase by more than 30% in the next three years.
